Literature DB >> 16106171

New surgical approach in facial transplantation extends survival of allograft recipients.

Sakir Unal1, Galip Agaoglu, James Zins, Maria Siemionow.   

Abstract

We have previously developed a composite total face-scalp allotransplantation model based on bilateral common carotid arteries (CCA) and external jugular veins. To decrease the mortality rates, different modifications of arterial anastomoses in the facial allograft recipients are presented. Eighteen full face-scalp allograft transplantations were performed across major histocompatibility (MHC) barriers between ACI (RT1) donors and Lewis (RT1) recipients. Bilateral CCA and bilateral external carotid arteries of the recipients were used as recipient vessels to vascularize the flap in 5 and 4 transplants, respectively. In 9 transplants, unilateral CCA of the recipients were used to vascularize the face/scalp flap. All the animals received CsA 16 mg/kg/d Sc, which was tapered over 4 weeks to 2 mg/kg/d. In transplants utilizing bilateral CCA, the survival rate of the animals was very short. Transplants in which unilateral CCA were used yielded 100% survivals over 200 days posttransplant. These modifications of arterial anastomoses have significantly improved survival of facial allograft recipients.

Entities:  

Mesh:

Year:  2005        PMID: 16106171     DOI: 10.1097/01.sap.0000168693.25306.79

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Facial transplantation.

Authors:  Maria Siemionow; Yalcin Kulahci
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

2.  Experimental models of composite tissue allograft transplants.

Authors:  Maria Siemionow; Yalcin Kulahci
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

Review 3.  Vascularized Composite Allografts: Procurement, Allocation, and Implementation.

Authors:  Axel Rahmel
Journal:  Curr Transplant Rep       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.